Molecular Imaging: Page 471

Bayer Schering to develop PET brain imaging agents

By AuntMinnie.com staff writers

Berlin-based Bayer Schering Pharma (formerly Schering) has signed a license and option agreement with two Japanese companies and the National Institute of Radiological Sciences (NIRS) in Japan to develop imaging compounds for detecting neurodegenerative diseases such as Alzheimer's and Parkinson's diseases.

January 18, 2007

IBA expands production capacity

By AuntMinnie.com staff writers

Nuclear medicine products firm Ion Beam Applications (IBA) has launched an expansion program to meet the demand for its proton therapy systems.

January 18, 2007

New tracer shows promise for PET/CT prostate imaging

By Jonathan S. Batchelor

One in six men in the U.S. will get prostate cancer during his lifetime, according to recent data. Unfortunately, conventional imaging techniques are limited for detecting, staging, and restaging this carcinoma. But a study by scientists at Emory University in Atlanta and researchers in Japan finds that a new radiotracer shows promse in evaluating and staging prostate cancer.

January 17, 2007

IsoRay adds cesium-131 sites

By AuntMinnie.com staff writers

Medical isotope developer IsoRay Medical has increased the number of sites either producing or getting ready to produce cesium-131.

January 16, 2007

Fuji renames Daiichi subsidiary

By AuntMinnie.com staff writers

Japanese film and technology company Fujifilm has applied its corporate branding to its recently acquired Daiichi Radioisotope Laboratories (DRL) subsidiary, with the division to be known as Fujifilm RI Pharma, effective April 1.

January 16, 2007

Neoprobe gets FDA nod for more Lymphoseek trials

By AuntMinnie.com staff writers

Gamma camera probe developer Neoprobe has received authorization from the U.S. Food and Drug Administration (FDA) to begin patient enrollment in two phase I clinical studies for its Lymphoseek targeting agent.

January 16, 2007